期刊文献+

法尼酯X受体上调载脂蛋白F在肝细胞中的表达

Farnesoid X receptor upregulates apolipoprotein F expression in cultured liver cells
下载PDF
导出
摘要 目的研究法尼酯X受体(farnesoid X receptor,FXR)的激活在肝细胞中对载脂蛋白F(apolipoprotein F,ApoF)基因表达的影响。方法应用逆转录-聚合酶链反应(RT-PCR)法和Western blot检测不同浓度鹅脱氧胆酸(chenodeoxy cholic acid,CDCA,0、25、50、100μmol/L)和人工合成FXR配体GW4064(0、0.02、0.2、2μmol/L)处理后HepG2和L02细胞中的小分子异二聚体伴侣(small heterodimer partner,SHP)及ApoF的mRNA和蛋白水平变化。结果结果①经FXR天然配体CDCA处理24 h后,不同浓度处理组细胞SHP mRNA水平、ApoF mRNA和蛋白水平均显著高于未处理组(P<0.05)。②经FXR人工合成配体GW4064处理24 h后,不同浓度处理组细胞SHP mRNA水平、ApoF mRNA和蛋白水平均显著高于未处理组(P<0.05)。结论肝细胞株HepG2和L02经FXR配体CDCA或GW4064处理后,FXR被激活,并上调ApoF的mRNA和蛋白水平。 Objective To determine the effect of farnesoid X receptor(FXR) on the expression of apolipoprotein F(ApoF) in human hepatoblastoma HepG2 cells and hepatocyte L02 cells.Methods After HepG2 cells and L02 cells were treated with FXR agonist chenodesoxycholic acid(CDCA) at 0,25,50 or 100 μmol/L,or with another agonist GW4064 at 0,0.02,0.2,or 2 μmol/L respectively,the mRNA expressions of FXR specific target gene small heterodimer partner(SHP) and ApoF were detected by reverse transcription polymerase chain reaction(RT-PCR).The apolipoprotein F protein level was determined by Western blotting.Results After treated with CDCA for 24 h,the mRNA levels of SHP and ApoF in the treated cells were significantly higher than the untreated cells(P0.05),so did the protein expression of ApoF(0.884±0.091 vs 0.185±0.030,P0.05).After treated with GW4064 for 24 h,the SHP and ApoF expressions at mRNA level were significantly increased in the treated cells than the untreated cells(P0.05),so did the protein expression of ApoF(P0.05).Conclusion After the treatment of CDCA and GW4064,FXR is activated in HepG2 cells and L02 cells,which upregulates the expression of apoF.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2011年第9期916-919,共4页 Journal of Third Military Medical University
基金 国家自然科学基金(81070228) 重庆市自然科学基金(CSTC2007BB5050)~~
关键词 法尼酯X受体 载脂蛋白F 胆固醇酯转运蛋白 Farnesoid X receptor apolipoprotein F cholesterol ester transfer protein
  • 相关文献

参考文献11

  • 1He F, Li J, Mu Y, et al. Downregulation of endothelin-1 by farnesoid X receptor in vascular endothelial cells [ J ]. Circ Res, 2006, 98 (2) : 192 - 199.
  • 2Paromov V M, Morton R E. Lipid transfer inhibitor protein defines the participation of high density lipoprotein subfractions in lipid transfer reactions mediated by cholesterol ester transfer protein (CETP) [J]. J Biol Chem, 2003, 278(42) : 40859 -40866.
  • 3Makishima M. Nuclear receptors as targets for drug development : regulation of cholesterol and bile acid metabolism by nuclear receptors [ J ]. J Pharmacol Sci, 2005, 97(2) : 177 - 183.
  • 4Morton R E, Gnizak H M, Greene D J, et al. Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects[J]. J Lipid Res, 2008, 49( 1 ) : 127 - 135.
  • 5Lu T T, Makishima M, Repa J J, et al. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors [ J ]. Mol Cell, 2000, 6(3) : 507 -515.
  • 6Izem L, Morton R E. Molecular cloning of hamster lipid transfer inhibitor protein ( apolipoprotein F) and regulation of its expression by hyperlipidemia[ J]. J Lipid Res, 2009, 50(4) : 676 -684.
  • 7Wang X, Driscoll D M, Morton R E. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity With apolipoprotein F[J]. J Biol Chem, 1999, 274(3): 1814-1820.
  • 8Koren E, McConathy W J, Alaupovic P. Isolation and characterization of simple and complex lipoproteins containing apolipoprotein F from human plasma [ J]. Biochemistry, 1982, 21 (21) : 5347 - 5351.
  • 9Shah P K. Inhibition of CETP as a novel therapeutic strategy for reducing the risk of atherosclerotic disease[ J]. Eur Heart J, 2007, 28 (1): 5 -12.
  • 10董金瑜,刘红,彭家和,张艳,王强,李良鹏,王永超,江渝.法尼酯X受体可下调肝细胞中肝型脂肪酸结合蛋白的表达[J].第三军医大学学报,2010,32(5):458-461. 被引量:2

二级参考文献21

  • 1Huber R M, Murphy K, Miao B, et al. Generation of multiple fame-sold-X-receptor isoforms through the use of ahemative promoters [ J ]. Gene, 2002, 290(1/2) : 35 -43.
  • 2Willson T M, Jones S A, Moore J T, et al. Chemical genomics: functional analysis of orphan nuclear receptors in the regulation of bile acid metabolism[J]. MedResRev, 2001, 21(6):513-522.
  • 3Cariou B, van-Harmelen K, Duran-Sandoval D, et al. The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice [J]. J Biol Chem,2006, 281(16): 11039-11049.
  • 4Watanabe M, Houten S M, Wang L, et al. Bile acids lower triglycefide levels via a pathway involving FXR, SHP, and SREBP-lc[J]. J Clin Invest , 2004, 113(10) : 1408 - 1418.
  • 5Wang Y D, Chen W D, Huang W. FXR, a target for different diseases [ J ]. Histol Histopathol, 2008, 23 (5) : 621 - 627.
  • 6Pineda-Torra 1, Claudel T, Duval C, et al. Bile acids induce the ex- pression of the human peroxisome proliferator-activatcd receptor alpha gene via activation of the farnesoid X receptor [J].Mol Endocrinol, 2003, 17(2) : 259 -272.
  • 7Zhang Y, Castellani L W, Sinal C J, et al. Peroxisome proliferator- activated receptor-gamma coactivator I alpha ( PGC-I alpha ) regulates triglyceride metabolism by activation of the nuclear receptor FXR [ J ]. Genes Deny, 2004, 18(2): 157-169.
  • 8Storch J, Thumser A E. The fatty acid transport function of fatty acid- binding proteins[J]. Biochim Biophys Acta, 2000, 1486 (1) : 28 -44.
  • 9NewbeiTy E P, Xie Y, Kennedy S, et al. Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene [ J ]. J Biol Chem, 2003, 278(51 ) : 51664 -51672.
  • 10Newberry E P, Xie Y, Kennedy S M, et al . Protectiun against Western diet-induced obesity and hepatic steatosis in liver fatty acidbinding protein knockout mice[J].Hepatology, 2006, 44 (5) : 1191 - 1205.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部